期刊文献+

P16、PTEN、E-cadherin、CtBP1联合检测对子宫内膜腺癌的诊断意义 被引量:2

Diagnostic value of the expression of P16,PTEN,E-cadherin and CtBP1 in endometrial cancer
下载PDF
导出
摘要 目的研究P16、PTEN、E-cadherin、CtBP1在子宫内膜癌中的表达,评价联合检测三者对子宫内膜癌临床病理诊断的意义。方法使用组织芯片和免疫组化染色技术观察P16、PTEN、E-cadherin、CtBP1在60例子宫内膜腺癌和30例正常子宫内膜组织中的表达情况,使用二元逻辑回归ROC曲线分析方法对联合检测指标进行筛选,并对个体诊断进行预测。结果 P16、PTEN、E-cadherin在子宫内膜癌中的阳性表达率高于正常子宫内膜(P<0.05);CtBP1在两种组织中均高度表达,未见显著差异(P>0.05)。P16和PTEN联合检测具有中等强度准确性,在假阳性率为10%的条件下诊断点为0.900。结论 P16、PTEN、E-cadherin阳性表达与子宫内膜癌发生有关;P16和PTEN联合检测对子宫内膜腺癌的临床病理诊断有参考价值。 Objective To evaluate the diagnostic value of the expression of P16,PTEN,E-cadherin and CtBP1 in endometrial cancer.Methods Sixty endometrial cancer tissues and thirty normal endometrial tissues were enrolled in the research.The expression of P16,PTEN,E-cadherin and CtBP1 were measured by tissue microarray technology and immunohistochemical method.Then,the diagnostic value of the expression of P16,PTEN,E-cadherin and CtBP1 were evaluated by using binary logistic regression analysis(ROC curve).Results Positive expression of P16,PTEN and E-cadherin in endometrial cancer were significantly higher than those in normal endometrial tissues(P0.05).Positive expression of CtBP1 in two groups were both higher but no significant difference between them(P0.05).P16 combined with PTEN achieved medium intensity as diagnostic index for endometrial cancer,under the condition of 10% false positive rate,diagnostic point of endometrial cancer was defined as 0.900.Conclusions Positive expression of P16,PTEN,E-cadherin might be correlated with tumorigenesis of endometrial cancer.Combined detection of P16 and PTEN had clinical value to diagnose endometrial cancer.
出处 《山东医药》 CAS 北大核心 2010年第24期26-28,共3页 Shandong Medical Journal
关键词 子宫内膜样 芯片分析技术 免疫组织化学 carcinoma endometrioid microchip analytical procedures immunohistochemistry
  • 相关文献

参考文献7

二级参考文献61

  • 1贾学玲,高云荷,张煦.子宫内膜增生及内膜癌中PTEN、Ki-67蛋白的表达[J].临床与实验病理学杂志,2003,19(2):152-155. 被引量:19
  • 2Negri G, Bellisano G, Zannoni G F, et al. p16ink4a and HPV L1 immunohistoehemistry is helpful for estimating the behavior of lowgrade dysplastie lesions of the cervix uteri [ J]. Am J Surg Pathol, 2008,32( 11 ) :1715 - 1720.
  • 3Branca M,Ciotti M, Santini D, et al. p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome [ J ]. Int J Gynecol Pathol, 2004,23 (4) :354 - 365.
  • 4Melsheimer P, Kaul S, Dobeck S, et al. Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA [ J ]. Acta Cytol, 2003,47(2) :124 - 128.
  • 5Griesser H, Sander H, Hilfrich R, et al. Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia[ J]. Anal Quant Cytol Histol, 2004,26(5) :241 -245.
  • 6Lee H, Lee K J, Jung C K, et al. Expression of HPV L1 capsid protein in cervical specimens with HPV infection [ J ]. Diagn Cytopathol,2008,36 ( !2 ) : 864 - 867.
  • 7Kruse A J, Skaland I, Janssen E A, et al. Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability[ J]. Int J Gynecol Pathol, 2004,23 (2) : 100 - 109.
  • 8Kurvinen K, Syrjanen K, Syrjanen S. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions[J]. J Clin Oncol,1996,14(7) :2120 -2130.
  • 9Wang J L, Zheng B Y, Li X D, et al. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer [ J ]. Clin Cancer Res, 2004,10 ( 7 ) : 2407 - 2414.
  • 10Yoshida T, Sano T, Kanuma T, et al. Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions [ J ]. Cancer, 2008,114 ( 2 ) : 83 -88:.

共引文献365

同被引文献27

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部